Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation
Autor: | Harry B. Hines, Lisa A. Ridnour, Tiffany H. Dorsey, Kimberly M. Barasch, Robert Y.S. Cheng, Ernst E. Brueggemann, Stefan Ambs, David A. Wink, Christopher H. Switzer, Michael M. Lizardo, Dong H. Lee, Harris G. Yfantis, Alisha N. Windhausen, Chand Khanna, Sharon A. Glynn, Julie L. Heinecke |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2012 |
Předmět: |
CD36 Antigens
Colorectal cancer lcsh:Medicine Signal Initiation Molecular Cell Biology Breast Tumors Phosphorylation lcsh:Science Microscopy Confocal Multidisciplinary Chemistry Mechanisms of Signal Transduction Obstetrics and Gynecology Immunohistochemistry Signaling Cascades Gene Expression Regulation Neoplastic Treatment Outcome Oncology Medicine Female Signal transduction Signal Transduction Research Article Feedback Regulation Breast Neoplasms Phosphoinositide Signal Transduction Nitric Oxide Signaling Pathways Gene Expression Regulation Enzymologic Cell surface receptor Breast Cancer Akt Signaling Cascade medicine Humans Biology Protein kinase B PI3K/AKT/mTOR pathway Tissue Inhibitor of Metalloproteinase-1 lcsh:R Cancers and Neoplasms Cancer Oligonucleotides Antisense medicine.disease Molecular biology Enzyme Activation Cancer cell Cancer research lcsh:Q Nitric Oxide Synthase Proto-Oncogene Proteins c-akt |
Zdroj: | PLoS ONE, Vol 7, Iss 9, p e44081 (2012) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Prediction of therapeutic response and cancer patient survival can be improved by the identification of molecular markers including tumor Akt status. A direct correlation between NOS2 expression and elevated Akt phosphorylation status has been observed in breast tumors. Tissue inhibitor matrix metalloproteinase-1 (TIMP-1) has been proposed to exert oncogenic properties through CD63 cell surface receptor pathway initiation of pro-survival PI3k/Akt signaling. We employed immunohistochemistry to examine the influence of TIMP-1 on the functional relationship between NOS2 and phosphorylated Akt in breast tumors and found that NOS2-associated Akt phosphorylation was significantly increased in tumors expressing high TIMP-1, indicating that TIMP-1 may further enhance NO-induced Akt pathway activation. Moreover, TIMP-1 silencing by antisense technology blocked NO-induced PI3k/Akt/BAD phosphorylation in cultured MDA-MB-231 human breast cancer cells. TIMP-1 protein nitration and TIMP-1/CD63 co-immunoprecipitation was observed at NO concentrations that induced PI3k/Akt/BAD pro-survival signaling. In the survival analysis, elevated tumor TIMP-1 predicted poor patient survival. This association appears to be mainly restricted to tumors with high NOS2 protein. In contrast, TIMP-1 did not predict poor survival in patient tumors with low NOS2 expression. In summary, our findings suggest that tumors with high TIMP-1 and NOS2 behave more aggressively by mechanisms that favor Akt pathway activation. |
Databáze: | OpenAIRE |
Externí odkaz: |